HHT
Research
News & Resources
Who We Are
Guidelines
Get Involved
Ways to Donate

Contact Us
Join Us
Cure HHT Canada
Research Hub
Donate

HHT
Research
News & Resources
Who We Are
Guidelines
Get Involved
Ways to Donate

Drug Therapy

Drugs are approved in the U.S. by the Food and Drug Administration (FDA) for specific purposes to help guide medical practice.

Provider Topics

Anemia/ Iron Deficiency
Brain
HHT Continuing Education
Clinicians First Time Seeing a Patient with HHT
Drug Therapy
Gastrointestinal
Genetics
Heart
HHT in children
Insurance
International Guidelines for Screening and Treatment
Liver
Lungs
Nosebleeds or Epistaxis
Pregnancy & Women’s Issues
Skin
Useful Links to Outside Organizations

Advanced Search

Filter by Resource Type

Related Resources

Knowledge is Power: The 5 Biggest Changes in HHT Care (Recording)

Webinar – 2026

Our understanding of HHT is constantly evolving. If you haven’t been to a conference in a few years, or it’s been a while since you were last seen at an HHT Center of Excellence – this session is a must. In this Cure HHT webinar recording, we walk th…

Your Questions Answered: An Informative Session on an HHT Clinical Trial (Recorded)

Webinar – 2025

An informative webinar about hereditary hemorrhagic telangiectasia (HHT). The webinar is being run by Cure HHT and introduces an upcoming clinical trial evaluating whether an investigational medication has the potential to treat HHT. During this sess…

Entering the Therapeutics Age: A New Era for HHT Treatment (Recorded)

Webinar – 2024

Lately, there’s been an exciting wave of news about HHT therapies. Several clinical trials are now underway, biotech companies are investing heavily in HHT research, and new treatments are closer than ever to becoming reality. We’re entering this new…

NEW Criteria! Groundbreaking Trial for HHT: Learn About Pazopanib (Recorded)

Webinar – 2024

Your questions answered about our newest clinical trial with NEW expanded criteria! Join Cassi Friday, PhD and Jim Gossage, MD as they explain who is now eligible, what Pazopanib is, and how you can get involved!

Pazopanib: A Groundbreaking Trial for HHT (Recording)

Webinar – 2023

Get your questions answered about our newest clinical trial! Join Cassi Friday, PhD and Jim Gossage, MD as they explain who is eligible, what Pazopanib is and how you can get involved!

Abstracts – 14th HHT International Scientific Conference (2022)

Scientific Literature – 2023

Angiogenesis. This article is open access and free for a certain period of time; otherwise, it is available for purchase directly from the publisher. Click to view resource.

Executive Summary – 14th HHT International Scientific Conference (2022)

Scientific Literature – 2023

Angiogenesis. This article is open access and free for a certain period of time; otherwise it is available for purchase directly from the publisher. Click to view resource.

Bedside to Bench: How the HHT Community Drives Research Initiatives (Recorded)

Webinar – 2021

In March 2020, Cure HHT was 1 of 30 organizations selected to participate in the Chan Zuckerberg Initiative (also known as CZI) Rare is One Project. This ambitious project is lifting up the work that patient communities are doing to accelerate resear…

Nuts and Bolts of A Clinical Trial – the PATH-HHT Study (Recorded)

Webinar – 2021

Research is the key to the future health and quality of life for HHT patients. “Diseases can only be cured when scientists understand them. This understanding, which comes from basic research, leads to new drugs and treatments.” ~Dr. Christopher Hugh…

International HHT Guidelines – Overview (Recorded)

Webinar – 2021

Join Dr. Marie Faughnan, Director, Toronto HHT Centre of Excellence as she provides an overview of the newly updated International HHT Guidelines and how they are used to set the standard of care globally for the diagnosis and treatment of HHT. Dr. F…

Bevacizumab (Avastin) Use In HHT

Policy Statement – 2020

Hereditary hemorrhagic telangiectasia (HHT, also known as OslerWeber-Rendu Syndrome) is a condition that is characterized by focal proliferation of blood vessels (vascular malformations) in multiple organs. Two of the most commonly affected organs in…

Bevacizumab for treating HHT patients with severe hepatic involvement or refractory anemia

Scientific Literature – 2020

PLoS One. Authors: Carolina Vázquez, María Laura Gonzalez, Augusto Ferraris, Juan Carlos Bandi, and Marcelo Martín Serra. This article is available for public use and does not require purchase. Click to view the full article.

The Science Behind the 2019 Scientific Conference (recorded)

Webinar – 2020

Philippe Marambaud, PhD and Andy White, MD discuss important advances in HHT research which were presented at the 2019 HHT International Scientific Conference in Puerto Rico. Learn about advancements in drug therapies for bleeding, screening and trea…

Orphanet-Journal-of-Rare-Diseases-Future-treatments-for-HHT

Future Treatments for Hereditary Hemorrhagic Telangiectasia

Scientific Literature – 2020

Orphanet Journal of Rare Diseases. Authors: Florian Robert, Agnès Desroches-Castan, Sabine Bailly, Sophie Dupuis-Girod and Jean-Jacques Feige. This article is available for public use and does not require purchase. Click to view the full article.

Systemic bevacizumab for high-output cardiac failure in HHT: an international survey of HHT centers

Scientific Literature – 2019

Orphanet Journal of Rare Diseases. Authors: Hanny Al-Samkari, Hasan A. Albitar, Scott E. Olitsky, Marianne S. Clancy and Vivek N. Iyer. This article is available for public use and does not require purchase. Click to view the full article.